Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer
NCT00282048
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Kidney Neoplasms
Carcinoma, Renal Cell
Interventions
DRUG:
AG-013736 (axitinib)
Sponsor
Pfizer